Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2024-02-06 | 2024-02-05 |
| Drug Identification Number | 02302381 | 02302381 |
| Brand name | SANDOZ LISINOPRIL HCT | SANDOZ LISINOPRIL HCT |
| Common or Proper name | LISINOPRIL HCT | LISINOPRIL HCT |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | HYDROCHLOROTHIAZIDE LISINOPRIL | HYDROCHLOROTHIAZIDE LISINOPRIL |
| Strength(s) | 25MG 20MG | 25MG 20MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 100TAB BO | 100TAB BO |
| ATC code | C09BA | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | ||
| Actual start date | 2024-02-05 | 2024-02-05 |
| Estimated end date | 2024-12-20 | 2024-12-20 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |